4.7 Article

A New Antitumor Arabinopyranoside from Laurencia majuscula Induces G2/M Cell Cycle Arrest

Journal

PHYTOTHERAPY RESEARCH
Volume 24, Issue 10, Pages 1447-1450

Publisher

WILEY-BLACKWELL
DOI: 10.1002/ptr.3153

Keywords

Laurencia majuscula; hexadecyl-1-O-alpha-L-arabinopyranoside; antitumor; cell proliferation; cell cycle arrest

Funding

  1. National High Technology Development Project (863 Project) [2006AA09Z408 GDSFC 06025194, 2005A30503001, 2006Z3-E4041]
  2. National Natural Science Fund [20772048]
  3. Medical Research Fund of Guangdong Province [B2006084]

Ask authors/readers for more resources

A new arabinopyranoside was isolated from the alga Laurencia majuscula (Harvey) Lucas, collected from the Xisha Islands in the South China Sea. Its structure was elucidated as hexadecyl-1-O-alpha-L-arabinopyranoside by spectroscopic analysis. It was found that arabinopyranoside had significant antitumor activity in LOVO and Bel-7402 cell lines. Flow cytometric analysis showed that arabinopyranoside arrested the cell cycle in the G2/M phase. Western blotting demonstrated that the protein expression of CDK1 and cyclin A related to the G2/M phase decreased markedly with arabinopyranoside treatment, with slight changes in cyclin B1 expression. Taken together, the findings identify a potential new antitumor therapeutic arabinopyranoside isolated from red alga Laurencia majuscula. Copyright (c) 2010 John Wiley & Sons, Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available